Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Nokia | 1.38% | $18.08M | $36.26B | 41.43% | 66 Neutral | |
| Roche Holding AG | 1.19% | $15.69M | CHF273.54B | 46.09% | 73 Outperform | |
| Engie SA | 1.19% | $15.66M | €57.65B | 48.85% | 64 Neutral | |
| GlaxoSmithKline | 1.16% | $15.25M | $101.66B | 55.55% | 77 Outperform | |
| Toronto Dominion Bank | 1.14% | $15.01M | $158.85B | 69.57% | 74 Outperform | |
| Royal Bank Of Canada | 1.04% | $13.70M | $237.11B | 41.04% | 75 Outperform | |
| Novartis AG | 1.03% | $13.51M | CHF216.66B | 26.11% | 80 Outperform | |
| Centrica | 1.00% | $13.09M | £8.21B | 34.04% | 66 Neutral | |
| Bank Of Montreal | 0.99% | $13.04M | C$131.81B | 33.32% | 74 Outperform | |
| Fairfax Financial Holdings | 0.99% | $13.01M | $44.00B | 32.18% | 81 Outperform |